Quick Answer
Ensysce Biosciences, Inc. reported Common Stock Shares Outstanding of 4.57 million shares for the year ending 2025.
- Ensysce Biosciences, Inc. showed an increase of +237.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Ensysce Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2017 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2017 to 2025), Ensysce Biosciences, Inc.'s Common Stock Shares Outstanding has declined by 32.1%.
- Historical annual values: Fiscal year 2025: 4.57 million shares | Fiscal year 2024: 1.36 million shares | Fiscal year 2023: 209,739 shares | Fiscal year 2022: 534,490 shares | Fiscal year 2021: 1.23 million shares | Fiscal year 2021: 310,963 shares | Fiscal year 2020: 15.77 million shares | Fiscal year 2019: 6.38 million shares | Fiscal year 2018: 6.04 million shares | Fiscal year 2017: 6.73 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: